论文部分内容阅读
目的 对比双腔管与常规单腔管冲洗引流并尿激酶溶解术治疗高血压脑出血的临床效果。方法 将 73例高血压脑出血患者分为治疗组和对照组 ,治疗组 43例采用双腔管冲洗引流 ,对照组 3 0例用常规单腔管冲洗引流 ,两组均并用尿激酶溶解术。两组病例入院和治疗后评判标准采用中国卒中量表 ( CSS)评分 ,6个月后随访 ,用 Barthe L指数日常生活能力量表 ( ADL)评分。结果 术后 2 0天血肿的消除吸收率治疗组为 92 .1 %,显著高于对照组的 79.1 %( χ2= 8.4885 ,P <0 .0 5 ) ;6个月后随访 Barthe L指数 ADL评分 ,治疗组为 ( 82 .5± 1 4 .84)分 ,显著高于对照组的 ( 71 .1 3±2 0 .0 7)分 ( t=3 .1 5 91 ,P <0 .0 5 )。结论 双腔管冲洗引流并尿激酶溶解术治疗高血压脑出血血肿清除率高 ,死亡率和致残率低 ,临床疗效优于常规单腔管治疗
Objective To compare the clinical effects of double-lumen tube and conventional single-lumen tube irrigation and drainage and urokinase-dissolving in the treatment of hypertensive intracerebral hemorrhage. Methods Seventy-three patients with hypertensive intracerebral hemorrhage were divided into treatment group and control group. Forty-three patients in the treatment group received double-lumen tube drainage and 30 in control group received conventional single-lumen tube drainage. Both groups were treated with urokinase. The admission criteria and post-treatment evaluation criteria of the two groups were assessed using the Chinese Stroke Scale (CSS) score, followed up for 6 months and scored using the Barthel Index Daily Life Scale (ADL). Results The removal rate of hematoma after operation was 92.1% in the treatment group and 79.1% in the control group (χ2 = 8.4885, P <0.05). After 6 months, the Barthel Index ADL score (82.5 ± 14.48) in the treatment group, which was significantly higher than that in the control group (71.1 ± 20.07) (t = 3.1591, P <0.05 ). Conclusions The double-lumen tube drainage and urokinase-dissolving therapy has a high rate of hematoma removal, low mortality and morbidity in hypertensive intracerebral hemorrhage. The clinical curative effect is superior to conventional single lumen tube